- Tesla (TSLA.US) Shareholders Meeting Preview: Focus on Musk’s Compensation and Board Re-election, SpaceX Merger Rumors Heat Up
- Tesla (TSLA.US) Shareholders Meeting Preview: Musk’s Compensation and Director Re-election Draw Attention, SpaceX Merger Rumors Intensify
- Two supertankers hit mines and caught fire in the Strait of Hormuz, raising transit risks
- BUZZ - Bank of America upgrades chemical company Dow to "Neutral" rating and raises its target price
- ArriVent's Firmonertinib Shows 68% Response Rate at 240 mg in EGFR PACC-Mutant Lung Cancer Trial
- NRx Pharmaceuticals Completes Manufacturing Validation for Preservative-Free Ketamine
- Bersama Mencapai Puncak Announces Extraordinary Shareholders Meeting
- BrasilAgro Announces Annual and Extraordinary Shareholders Meeting
- Cytokinetics Wins Health Canada Approval for Myqorzo Heart Drug
- Copper Road Resources President and CEO Brian Howlett Steps Down
- Bitcoin volatility nears 2.5-year low as US spot ETFs see outflows
- --Canada's CPI Excluding Gasoline at 2.2% Y/Y in September
- H.B. Fuller Board Rejects Revised Ancora Proposal for Adhesives Business
- WAYSTAR HOLDING CORP. <WAY.O>: JEFFERIES RAISES TARGET PRICE TO $33 FROM $31
- Pomdoctor Plans 1-for-10 Share Consolidation on October 21
- Green Rise Foods agrees to acquisition by Pereira Verde
- Goldman Sachs cuts total voting rights in CECONOMY to 5.13% from 5.46%
- --Canada's CPI at 0.1% M/M in Non-Seasonally Adjusted Basis in September; Bloomberg Survey Saw at 0.2% M/M
- Expand Energy Appoints Daniel Brown as CEO
- TTM Technologies agrees to buy MKS's Ophir Optics business for $650 million
- DOXIMITY, INC. <DOCS.N>: JEFFERIES RAISES TARGET PRICE TO $29 FROM $20
- Cushman & Wakefield Publishes Update to Financial Calendar
- PHREESIA, INC. : JEFFERIES CUTS TARGET PRICE TO $17 FROM $20
- --Canada's CPI at 3.1% Y/Y in September; Bloomberg Survey Saw at 3.2% Y/Y
- Zone Frontier Announces 1-for-60 Reverse Stock Split Effective Oct. 30
- VinFast Q2 Revenue Rises 85.5% to USD 1.2 Billion
- Teuton Resources Identifies Broad Geophysical Anomaly at Clone Property
- Enlivex focuses resources on Allocetra Phase 2b knee osteoarthritis trial
- Eni completes Libya gas recovery project to curb CO₂ emissions
- AF Gruppen wins rehabilitation project for 361 apartments in Bergen
- Aeris Fiscal Council Endorses Second-Quarter 2026 Financial Statements for Disclosure
- Roadster soars, can Tesla (TSLA.US) spark another rally? Robotaxi and Optimus commercialization become focal points in the financial report.
- Micron Technology will hold a technical webinar on October 21, focusing on the AI storage roadmap.
- Silence Therapeutics to be Acquired by Merck KGaA for $20 Per ADS
- --Earnings Flash (VFS) VinFast Auto Posts Q2 Net Loss From Continuing Operations 13,321 Vietnamese Dong a Share
- Stock Futures Rise as Investors Make Cautious Return to Risk -- Update
- Canadian Dollar Climbs as Alberta Vote Poses Little Threat, Rosenberg Research Says
- --Earnings Flash (VFS) VinFast Auto Posts Q2 Total Revenue 30.341T Vietnamese Dong
- Siebert Financial sees technology selloff as market rotation, not systemic panic
- Black Monday Alert: Will Wall Street’s Open Spark a Bitcoin Crash?
- Radnostix, NANO Nuclear seek NRC consent for license transfer tied to asset sale
- Chord Energy Appoints Michael Lou Chief Executive; Reports Preliminary Q3 Results
- Chorus Aviation to Acquire SkyCare Air Ambulance for CA$40 Million
- Hyperion DeFi Schedules Third-Quarter Earnings Call
- QTREX Regains Compliance With Nasdaq Minimum Bid Price Requirement
- Expand Energy Names Danny Brown President and CEO
- Marisa Board Approves R$ 18 Million Commercial Note Issue
- Vaxart Appoints Retired Vice Admiral Raquel C. Bono to Board
- Mattel Names Peter Griffith as CFO
- Envolve Capital Fund Brings Entire 217 MW Renewable Energy Portfolio Online
- Teako Minerals Begins Geophysical Survey at Tynset Copper-Zinc-Silver Project in Norway
- Dynex Capital Q3 Non-GAAP Earnings Rise
- ReconAfrica Begins Horizontal Drilling at Kavango West 1X
- DarkIris Sets 1-for-50 Share Consolidation for Oct. 22
- Pyxis Tankers presents Q2 adjusted EBITDA of $6.5 million, strongest quarter in seven quarters
- BetterLife Pharma Names Richard B. Lipton Co-Chair of Scientific Advisory Board
- Total Energy Services Plans Buyback of Up to 1,815,000 Shares, or 5% of Outstanding Stock
- Blackstone closes fifth energy transition fund at $8.7 billion
- Nation Gold plans up to 15 drillholes at Bonito gold-silver project in New Mexico
- Micron Hosts Technology Webinar on AI Memory and Storage Roadmap
- KinderCare CFO to Attend J.P. Morgan Ultimate Services Investor Conference
- TransCode Therapeutics to Present TTX-MC138 Phase 1a Trial Data at ESMO 2026
- Cosa Resources drilling intersects graphitic faulting at Aurora uranium project
- Core Molding Technologies publishes update to financial calendar
- Data I/O Seeks Shareholder Approval to Issue Common Stock Exceeding 19.9% of Outstanding Shares
- Atossa Therapeutics Staples One Contingent Value Right to Each Common Share
- Updated version 1-EyePoint to lay off half its staff following failure of second late-stage clinical trial for experimental drug
- Data I/O: Total Purchase Price Is $23M, Paid in a Combination of Cash and Co Common Stk >DAIO
- CDNL Amends Payment Structure for $357.5 Million Acquisition of Hughes Brothers Construction
- Merck KGaA agrees to acquire Silence Therapeutics for $20 per ADS
- TTM Technologies Transaction Is Expected to Close in the 2Q of 2027 >TTMI
- Stephens Adjusts PNC Financial Services Price Target to $250 From $265
- Chardan Initiates MannKind at Buy With $10 Price Target
- IRulya Therapeutics Presents LAM-001 Phase 2a Data in Pulmonary Hypertension
- PARAMOUNT RESOURCES LTD : JEFFERIES RAISES TARGET PRICE TO C$41 FROM C$37
- --Silence Therapeutics to be Acquired by Merck KGaA for $20 Per ADS
- Vizsla Copper starts first drilling program at Copperview project in British Columbia
- STRATHCONA RESOURCES LTD <SCR.TO>: JEFFERIES RAISES TARGET PRICE TO C$58 FROM C$56
- Jefferies & Co Adjusts Estee Lauder Price Target to $120 From $100
- BofA Adjusts PT on International Flavors & Fragrances to $95 From $101, Keeps Buy Rating
- DiaMedica Therapeutics Reschedules Fetal Growth Restriction Webinar
- --BofA Adjusts Price Target on Nutrien to $80 From $76, Keeps Buy Rating
- TOURMALINE OIL <TOU.TO>: JEFFERIES RAISES TARGET PRICE TO C$74 FROM C$72
- ORIC Pharmaceuticals to Present Phase 1b Enozertinib Data in First-Line Lung Cancer at ESMO 2026
- Cosciens raises approximately USD 12 million in unsecured convertible debenture offering
- Marqeta Expands Block Partnership to Power Square Credit Card on American Express Network
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- WidePoint outlines $45 million SaaS contract with major US mobile carrier
- OFA Group to Attend Public-Private Dialogue on Coastal Green Space Development
- Merck KGaA agrees to acquire Silence Therapeutics for $20 per ADS
- Dynex Capital Swings to Q3 2026 Net Loss of $335.54 Million From Prior-Quarter Profit
- Clene Seeks FDA Accelerated Approval for CNM-Au8 in ALS
- Johnson & Johnson's Tremfya maintains fistula remission through 48 weeks in Crohn's trial
- Mattel Names Peter Griffith CFO and Board Director
- NATIONAL CINEMEDIA INC <NCMI.O>: B. RILEY CUTS TARGET PRICE TO $2.5 FROM $3.75
- Framery Group updates financial calendar
- Altimmune's pemvidutide reduces liver fibrosis markers in Phase 2b MASH trial